エソテリック検査市場規模、シェア、競争環境、トレンド分析レポート：タイプ別（腫瘍学検査、遺伝子検査、免疫学検査、感染症検査、内分泌学検査、毒物学検査、神経学検査、その他）、 技術別（酵素結合免疫吸着測定法、質量分析法、DNAシークエンシング、化学発光免疫測定法、リアルタイムポリメラーゼ連鎖反応法、フローサイトメトリー、その他）、エンドユーザー別（独立系およびリファレンスラボ、病院系ラボ）： 2025年から2033年までの機会分析および業界予測

レポートID : ROJP0325527  |  発行日 : 2025年03月  |  フォーマット :  :   : 

無料サンプル   

試読申込  

見積もり  

1 : INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

2 : EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

3 : MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter’s five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rising Geriatric Population Pushes the Growth of the Global Market
    • 3.4.2. Restraints
      • 3.4.2.1. High Capital Investments and Low-Cost-Benefit Ratio for Biomarkers May Impede the Growth of the Market
    • 3.4.3. Opportunities
      • 3.4.3.1. Emerging Application in Oncology Drives the Growth of the Market

4 : ESOTERIC TESTING MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Oncology Testing
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Genetic Testing
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Immunology Testing
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Infectious Diseases Testing
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Endocrinology testing
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country
  • 4.7. Toxicology Testing
    • 4.7.1. Key market trends, growth factors and opportunities
    • 4.7.2. Market size and forecast, by region
    • 4.7.3. Market share analysis by country
  • 4.8. Neurology Testing
    • 4.8.1. Key market trends, growth factors and opportunities
    • 4.8.2. Market size and forecast, by region
    • 4.8.3. Market share analysis by country
  • 4.9. Other Testings
    • 4.9.1. Key market trends, growth factors and opportunities
    • 4.9.2. Market size and forecast, by region
    • 4.9.3. Market share analysis by country

5 : ESOTERIC TESTING MARKET, BY TECHNOLOGY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Enzyme-linked Immunosorbent Assay
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Mass Spectrometry
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. DNA Sequencing
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Chemiluminescence Immunoassay
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Real Time Polymerase Chain Reaction
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country
  • 5.7. Flow Cytometry
    • 5.7.1. Key market trends, growth factors and opportunities
    • 5.7.2. Market size and forecast, by region
    • 5.7.3. Market share analysis by country
  • 5.8. Other Technologies
    • 5.8.1. Key market trends, growth factors and opportunities
    • 5.8.2. Market size and forecast, by region
    • 5.8.3. Market share analysis by country

6 : ESOTERIC TESTING MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Independent and Reference Laboratories
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Hospital-based Laboratories
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

7 : ESOTERIC TESTING MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Technology
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
        • 7.2.5.1.1. Market size and forecast, by Type
        • 7.2.5.1.2. Market size and forecast, by Technology
        • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
        • 7.2.5.2.1. Market size and forecast, by Type
        • 7.2.5.2.2. Market size and forecast, by Technology
        • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
        • 7.2.5.3.1. Market size and forecast, by Type
        • 7.2.5.3.2. Market size and forecast, by Technology
        • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Technology
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
        • 7.3.5.1.1. Market size and forecast, by Type
        • 7.3.5.1.2. Market size and forecast, by Technology
        • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
        • 7.3.5.2.1. Market size and forecast, by Type
        • 7.3.5.2.2. Market size and forecast, by Technology
        • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
        • 7.3.5.3.1. Market size and forecast, by Type
        • 7.3.5.3.2. Market size and forecast, by Technology
        • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
        • 7.3.5.4.1. Market size and forecast, by Type
        • 7.3.5.4.2. Market size and forecast, by Technology
        • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
        • 7.3.5.5.1. Market size and forecast, by Type
        • 7.3.5.5.2. Market size and forecast, by Technology
        • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
        • 7.3.5.6.1. Market size and forecast, by Type
        • 7.3.5.6.2. Market size and forecast, by Technology
        • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Technology
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
        • 7.4.5.1.1. Market size and forecast, by Type
        • 7.4.5.1.2. Market size and forecast, by Technology
        • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
        • 7.4.5.2.1. Market size and forecast, by Type
        • 7.4.5.2.2. Market size and forecast, by Technology
        • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
        • 7.4.5.3.1. Market size and forecast, by Type
        • 7.4.5.3.2. Market size and forecast, by Technology
        • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
        • 7.4.5.4.1. Market size and forecast, by Type
        • 7.4.5.4.2. Market size and forecast, by Technology
        • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. Rest of Asia-Pacific
        • 7.4.5.5.1. Market size and forecast, by Type
        • 7.4.5.5.2. Market size and forecast, by Technology
        • 7.4.5.5.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Technology
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
        • 7.5.5.1.1. Market size and forecast, by Type
        • 7.5.5.1.2. Market size and forecast, by Technology
        • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
        • 7.5.5.2.1. Market size and forecast, by Type
        • 7.5.5.2.2. Market size and forecast, by Technology
        • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
        • 7.5.5.3.1. Market size and forecast, by Type
        • 7.5.5.3.2. Market size and forecast, by Technology
        • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
        • 7.5.5.4.1. Market size and forecast, by Type
        • 7.5.5.4.2. Market size and forecast, by Technology
        • 7.5.5.4.3. Market size and forecast, by End User

8 : COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

9 : COMPANY PROFILES

  • 9.1. ARUP Laboratories
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Athena Esoterix, LLC
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
  • 9.3. Bruker
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. F. Hoffmann-La Roche Ltd
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Laboratory Corporation of America Holdings
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Mayo Foundation for Medical Education and Research (MFMER)
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Quest Diagnostics
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. Sonic Healthcare Limited .
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
Booklet
  • 発行日 :
    Mar-2025
  • 予想年 :
    2025年～2033年
  • 納期 :
    即日から翌営業日

レポート言語： 英語、日本語

無料サンプルPDF

   無料サンプルを入手する arrow icn

この無料サンプルには、トレンド分析から推定・予測まで、さまざまなデータが含まれています。

またはライセンスオプションをご覧ください:

最新レポート

お問い合わせ

マルチレポートプラン
必要なレポート数に応じて、カスタマイズされたプランをご提供します.
2024年の予算を無駄にしないでください！
残りの予算を活用して、将来の成功を確かなものにしましょう。

データに基づく貴重な洞察で、2025年を力強くスタートさせてください。

JAPAN : 03-6899-2648

[email protected]

東京都中央区八丁堀四丁目4番4号3階